In pancreatic cancer, BCL9L knockdown decreases cell proliferation, migration, invasion, and liver metastasis, and increases E-cadherin expression even in the presence of TGF-β, suggesting a role of BCL9L in regulating EMT31. This evidence concerns the gene BCL9L and pancreatic neoplasm.